TITLE

Increased prevalence of left ventricular hypertrophy in hypertensive women with type 2 diabetes mellitus

AUTHOR(S)
Tenenbaum, Alexander; Fisman, Enrique Z.; Schwammenthal, Ehud; Adler, Yehuda; Benderly, Michal; Motro, Michael; Shemesh, Joseph
PUB. DATE
January 2003
SOURCE
Cardiovascular Diabetology;2003, Vol. 2, p14
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Left ventricular hypertrophy (LVH) is a powerful independent risk factor for cardiovascular morbidity and mortality among hypertensive patients. Data regarding relationships between diabetes and LVH are controversial and inconclusive, whereas possible gender differences were not specifically investigated. The goal of this work was to investigate whether gender differences in left heart structure and mass are present in hypertensive patients with type 2 diabetes. Methods: Five hundred fifty hypertensive patients with at least one additional cardiovascular risk factor (314 men and 246 women, age 52 to 81, mean 66 ± 6 years), were enrolled in the present analysis. In 200 (36%) of them — 108 men and 92 women — type 2 diabetes mellitus was found upon enrollment. End-diastolic measurements of interventricular septal thickness (IVS), LV internal diameter, and posterior wall thickness were performed employing two-dimensionally guided M-mode echocardiograms. LVH was diagnosed when LV mass index (LVMI) was >134 g/m² in men and >110 g/m² in women. Results: Mean LVMI was significantly higher among diabetic vs. nondiabetic women (112.5 ± 29 vs. 105.6 ± 24, p = 0.03). In addition, diabetic women presented a significantly higher prevalence of increased IVS thickness, LVMI and left atrial diameter on intra-gender comparisons. The age adjusted relative risk for increased LVMI in diabetics vs. nondiabetics was 1.47 (95% CI: 1.0-2.2) in females and only 0.8 (0.5-1.3) in males. Conclusion: Type 2 diabetes mellitus was associated with a significantly higher prevalence of LVH and left atrial enlargement in hypertensive women.
ACCESSION #
28683661

 

Related Articles

  • Nonalcoholic Fatty Liver Disease Is Associated With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes. Bonapace, Stefano; Perseghin, Gianluca; Molon, Giulio; Canali, Guido; Bertolini, Lorenzo; Zoppini, Giacomo; Barbieri, Enrico; Targher, Giovanni // Diabetes Care;Feb2012, Vol. 35 Issue 2, p389 

    OBJECTIVE--Data on cardiac function in patients with nonalcoholic fatty liver disease (NAFLD) are limited and conflicting. We assessed whether NAFLD is associated with abnormalities in cardiac function in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS--We studied 50 consecutive type...

  • Sex-Specific Determinants of Left Ventricular Mass in Pre-Diabetic and Type 2 Diabetic Subjects. Kuch, Bernhard; Von Scheidt, Wolfgang; Peter, Wolfgang; Döring, Angela; Piehlmeier, Wolfgang; Landgraf, Rudiger; Meisinger, Christa // Diabetes Care;Apr2007, Vol. 30 Issue 4, p946 

    OBJECTIVE -- Obesity and hypertension are regarded as the most important determinants of left ventricular mass in the community. Little is known about sex-specific influences of obesity, hypertension, and other risk factors on left ventricular mass in pre-diabetic or diabetic subjects. RESEARCH...

  • Gender differences in factors influencing electrocardiographic findings of left ventricular hypertrophy in severe aortic stenosis. Satoh, Shinji; Omura, Soichiro; Inoue, Hiroko; Ejima, Emiko; Shimozono, Koutatsu; Hayashi, Makiko; Mori, Takahiro; Takenaka, Katsuhiko; Kawamura, Natsumi; Numaguchi, Kotaro; Mori, Etsuo; Asoh, Akemi; Nakamura, Toshihiro; Hiyamuta, Koji // Heart & Vessels;Sep2014, Vol. 29 Issue 5, p659 

    We investigated gender differences in factors influencing the electrocardiographic (ECG) findings of left ventricular hypertrophy (LVH) in patients with severe aortic stenosis (AS). The functional and geometric responses of the left ventricle to chronic pressure overload, such as hypertension...

  • Circulating CD34-Positive Cell Number Is Associated With Brain Natriuretic Peptide Level in Type 2 Diabetic Patients. Okada, Sadanori; Makino, Hisashi; Nagumo, Ayako; Sugisawa, Takako; Fujimoto, Muneya; Kishimoto, Ichiro; Miyamoto, Yoshihiro; Yoshimasa, Yasunao; Kikuchi-Taura, Akie; Soma, Toshihiro; Taguchi, Akihiko // Diabetes Care;Jan2008, Vol. 31 Issue 1, p157 

    The article highlights a study on the association between circulating CD34+ cell levels and plasma brain natriuretic peptide (BNP) levels, a marker of left ventricular (LV) dysfunction, in older patients with type 2 diabetes. It was found that reduced circulating CD34+ cell numbers are...

  • Left Ventricular Hypertrophy by Electrocardiogram. Kannel, William B.; Gordon, Tavla; Offutt, Dorsey // Annals of Internal Medicine;Jul69, Vol. 71 Issue 1, p89 

    Presents a study which examined the prevalence, incidence and mortality of left ventricular hypertrophy. Information on the disease; Methodology of the study; Results and discussion.

  • Subclinical LV dysfunction and 10-year outcomes in type 2 diabetes mellitus. Holland, David J.; Marwick, Thomas H.; Haluska, Brian A.; Leano, Rodel; Hordern, Matthew D.; Hare, James L.; Zhi You Fang; Prins, Johannes B.; Stanton, Tony // Heart;Jul2015, Vol. 101 Issue 13, p1061 

    Objective New imaging techniques have permitted the detection of subclinical LV dysfunction (LVD) in up to half of patients with type 2 diabetes mellitus (DM) with a normal EF. However, the connection between early LVD and prognosis is unclear. This study aimed to define the long-term outcome of...

  • Diabetic heart disease: the story continues. Shang, Q.; Yip, G. W.-K. // Journal of Human Hypertension;Mar2011, Vol. 25 Issue 3, p141 

    In this article the author discusses the association between type II diabetes mellitus and cardiovascular diseases including endothelial dysfunction, myocyte apoptosis and increased left ventricular (LV) mass with concentric hypertrophy. The authors explore the study by Nardi and colleagues,...

  • Preventing Left Ventricular Hypertrophy by ACE Inhibition in Hypertensive Patients With Type 2 Diabetes. Ruggenenti, Piero; Iliev, Ilian; Costa, Grazia Maria; Parvanova, Aneliya; Perna, Annalisa; Giuliano, Giovanni Antonio; Motterlini, Nicola; Ene-Iordache, Bogdan; Remuzzi, Giuseppe // Diabetes Care;Aug2008, Vol. 31 Issue 8, p1629 

    OBJECTIVE -- In patients with type 2 diabetes, left ventricular hypertrophy (LVH) predicts cardiovascular events, and the prevention of LVH is cardioprotective. We sought to compare the effect of ACE versus non-ACE inhibitor therapy on incident electrocardiographic (ECG) evidence of LVH...

  • Hypertension Is a Conditional Factor for the Development of Cardiac Hypertrophy in Type 2 Diabetic Mice. van Bilsen, Marc; Daniels, Anneleen; Brouwers, Olaf; Janssen, Ben J. A.; Derks, Wouter J. A.; Brouns, Agnieszka E.; Munts, Chantal; Schalkwijk, Casper G.; van der Vusse, Ger J.; van Nieuwenhoven, Frans A. // PLoS ONE;Jan2014, Vol. 9 Issue 1, p1 

    Background: Type 2 diabetes is frequently associated with co-morbidities, including hypertension. Here we investigated if hypertension is a critical factor in myocardial remodeling and the development of cardiac dysfunction in type 2 diabetic db/db mice. Methods: Thereto, 14-wks-old male db/db...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics